The clinical information you need, at your fingertips.

Focal segmental glomerulosclerosis is a heterogeneous podocytopathy that causes progressive proteinuric kidney disease and represents a leading cause of nephrotic syndrome and end-stage kidney disease. . .

Phase 2 trial finds elraglusib plus standard chemotherapy improves survival in a hard to treat population. . .

In a head-to-head trial, magnetic seizure therapy worked about as well as electroconvulsive therapy for severe depression and caused fewer memory problems. . .

A nine-protein blood test identified long-term kidney risk in Black adults carrying high-risk APOL1 variants who had normal kidney function, with the highest-risk group facing far more events over 10 years. . .

In statin-treated, high-risk patients, oral enlicitide lowered LDL‑C ~65% at 8 weeks—far exceeding ezetimibe and bempedoic acid—with similar short-term safety. . .

Short-term nitrogen dioxide exposure was associated with a markedly higher likelihood of migraine-related urgent care, while longer-term pollution exposure tracked with greater triptan use. . .

In a large cohort study, males who received the 9‑valent HPV vaccine had about a 46% lower risk of HPV‑related cancers compared with unvaccinated peers. . .

In a survey, roughly half of people with disordered eating reported harm from calorie labels, while about one-quarter reported benefit. . .

Small studies suggest GLP‑1–based treatments reduce binge eating and support weight loss, with mainly GI adverse effects. . .